John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 5,178 shares at $159.49 ($826K) on 2024-06-24, disclosed to the SEC on 2024-06-26.
Seasonal sale ($826k) by Chief Executive Officer — this insider has traded BGNE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.49 | 2,389 | $381K | 46.1% |
| 2 | $159.49 | 2,389 | $381K | 46.1% |
| 3 | $160.12 | 400 | $64K | 7.8% |
| Total | $159.54 avg | 5,178 | $826K | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |